To boost market growth, more regulatory approvals for new cetirizine formulations are being granted. During the forecast period, the global cetirizine hydrochloride market is projected to grow significantly. This is due to the fact that pharmaceutical businesses in the market are concentrating on creating innovative treatments. These advancements broaden the scope of cetirizine hydrochloride’s use in the treatment of ocular allergies and disorders. The FDA authorized Aciex Therapeutics, Inc.’s Zerviate ophthalmic solution for topical administration of the second-generation histamine-1 (H1) receptor antagonist for use in managing ocular irritation associated with allergic conjunctivitis in May 2017. The FDA granted clearance based on data from a New Drug Application that showed cetirizine ophthalmic solution’s effectiveness, safety, and acceptability in phase 3 clinical studies utilizing the conjunctival antigen challenge (CAC) paradigm. In September 2017, Nicox Ophthalmics, Inc., a Nicox S.A. division, signed an exclusive contract with Eyevance Pharmaceuticals LLC for the commercialization of Zerviatetm (cetirizine ophthalmic solution) 0.24 percent in the U.S., paving the way for the product’s expansion into new markets.
Request PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2069
Browse 28 Market Data Tables and 22 Figures spread through 148 Pages and in-depth TOC on “Cetirizine Hydrochloride Market – Global Forecast to 2026, by Dosage Form (Solution, Tablet, and Syrup), by Age Group (Pediatric and Adult), by Application (Eczema, Allergic Rhinitis, and Allergic Conjunctivitis), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Retail Pharmacies), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, and Africa).
Alliances are being used by market participants to expand their product portfolios by obtaining market access to cetirizine hydrochloride pipeline items and to better target important areas of the ophthalmic market, such as allergy and inflammation. Nicox S.A. purchased Aciex Therapeutics, Inc., a U.S.-based ophthalmic development pharmaceutical business with a robust late-stage treatment pipeline in ophthalmology, in 2014, expanding the product portfolio and obtaining marketing rights in the U.S. Also in 2017, the Bangalore-based pharmaceutical company Strides Shasun got FDA clearance for the allergy medication Cetirizine Hydrochloride in the United States. The product will be manufactured in the company’s flagship plant in Bangalore under the terms of the deal. Strides Pharma Inc. is the company that sells the medicine in the U.S.
Key Takeaways
Due to the introduction and clearance of medicines with innovative formulations and the rising prevalence of allergic rhinitis, the global cetirizine hydrochloride market is anticipated to grow at a CAGR of 3.2 percent over the forecast period.
The tablet sector dominates the global cetirizine hydrochloride market since it offers a less expensive option to other formulations, as well as a longer shelf life, improved absorption, and dissolving.
Due to the high prevalence of illness diagnosis among the pediatric population, as well as the group’s high vulnerability to allergic disease, the pediatric sector maintains a dominating position in the global cetirizine hydrochloride market.
Buy This Research Study Report For Quick Access@ https://www.coherentmarketinsights.com/insight/buy-now/2069
Due to the increasing incidence of hay fever in North America, Europe, and Asia Pacific, the hay fever sector has a dominating position in the global cetirizine hydrochloride market.
Key companies contributing in the global cetirizine hydrochloride market are Apotex, Inc., Strides Shasun, Nicox S.A., Mylan, Inc., Tris Pharma, Inc., Johnson and Johnson, Cipla Ltd., Jubilant Life Sciences, Aurobindo Pharma Limited, and Teva UK Limited.
Request For Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2069
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Dosage Form
- Market Snippet, By Age Group
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Regulatory Scenario
- Impact Analysis
- Key Highlights
- PEST Analysis
- Epidemiology
- Market Dynamics
- Global Cetirizine Hydrochloride Market, By Dosage Form, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Syrup
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Cetirizine Hydrochloride Market, By Age Group, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Cetirizine Hydrochloride Market, By Application, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Allergic Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Eczema
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Cetirizine Hydrochloride Market, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Cetirizine Hydrochloride Market, By Region, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Age Group, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837